Neuroscientist Fuyin Yang from Shanghai Jiao Tong University School of Medicine and colleagues examined the brains of 20 ...

Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s ...

For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, ...

Christopoulos, Dean of the Faculty of Pharmaceutical Sciences at Monash University, is at the centre of a significant ...

“This approval offers a new alternative to the antipsychotic medications people with schizophrenia have previously ... Researchers then used a rating system known as the Positive and Negative ...

A doctor working with Jacksonville's homeless population cites medical risks of marijuana and cautions against full ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs ... of outcome in patients with schizophrenia. Atypical antipsychotic drugs have been shown to be more ...

Researchers have developed the first 3D map of gene regulation in the human brain, offering insights into how early brain ...

Scientists have identified how genetic variants influence the risk of neurological and psychiatric disorders, including ...

Murder accused Wire Reddington compared himself to Jesus and claimed to have absorbed the hurt and pain of his fellow inmates ...

As marijuana legalization has accelerated across the country, doctors are contending with the effects of an explosion in the ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Today’s ...